1. Home
  2. TLSI vs HAIN Comparison

TLSI vs HAIN Comparison

Compare TLSI & HAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSI
  • HAIN
  • Stock Information
  • Founded
  • TLSI 2010
  • HAIN 1993
  • Country
  • TLSI United States
  • HAIN United States
  • Employees
  • TLSI N/A
  • HAIN N/A
  • Industry
  • TLSI Medical Specialities
  • HAIN Packaged Foods
  • Sector
  • TLSI Health Care
  • HAIN Consumer Staples
  • Exchange
  • TLSI Nasdaq
  • HAIN Nasdaq
  • Market Cap
  • TLSI 150.0M
  • HAIN 159.7M
  • IPO Year
  • TLSI N/A
  • HAIN 1993
  • Fundamental
  • Price
  • TLSI $4.80
  • HAIN $1.44
  • Analyst Decision
  • TLSI Strong Buy
  • HAIN Hold
  • Analyst Count
  • TLSI 5
  • HAIN 10
  • Target Price
  • TLSI $10.90
  • HAIN $3.48
  • AVG Volume (30 Days)
  • TLSI 95.6K
  • HAIN 1.9M
  • Earning Date
  • TLSI 11-13-2025
  • HAIN 09-15-2025
  • Dividend Yield
  • TLSI N/A
  • HAIN N/A
  • EPS Growth
  • TLSI N/A
  • HAIN N/A
  • EPS
  • TLSI N/A
  • HAIN N/A
  • Revenue
  • TLSI $35,990,000.00
  • HAIN $1,559,780,000.00
  • Revenue This Year
  • TLSI $56.79
  • HAIN $0.33
  • Revenue Next Year
  • TLSI $54.15
  • HAIN $1.02
  • P/E Ratio
  • TLSI N/A
  • HAIN N/A
  • Revenue Growth
  • TLSI 45.50
  • HAIN N/A
  • 52 Week Low
  • TLSI $3.42
  • HAIN $1.30
  • 52 Week High
  • TLSI $5.88
  • HAIN $9.43
  • Technical
  • Relative Strength Index (RSI)
  • TLSI 51.02
  • HAIN 34.80
  • Support Level
  • TLSI $4.41
  • HAIN $1.42
  • Resistance Level
  • TLSI $4.93
  • HAIN $2.17
  • Average True Range (ATR)
  • TLSI 0.28
  • HAIN 0.13
  • MACD
  • TLSI -0.05
  • HAIN -0.05
  • Stochastic Oscillator
  • TLSI 42.25
  • HAIN 2.67

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

About HAIN Hain Celestial Group Inc. (The)

The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas among others. It operates under two reportable segments; North America and International. The majority of its revenue is derived from the North America segment which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.

Share on Social Networks: